Ronald Zolty Pulmonary Hypertension Program, University of Nebraska Medical Center, Lied Transplant Center, Omaha, NE, USACorrespondence: Ronald Zolty 982265 Nebraska Medical Center, Room 8712, Omaha, NE, 68198-2265 Tel +1 4025595591Fax +1 4025598355Email ronald.zolty@unmc.eduAbstract: Pulmonary arterial hypertension (PAH) is a progressive and devastating disease characterized by pulmonary artery vasoconstriction and vascular remodeling leading to vascular rarefaction with elevation of pulmonary arterial pressures and pulmonary vascular resistance. Often PAH will cause death from right heart failure. Current PAH-targeted therapies improve functional capacity, pulmonary hemodynamics and reduce hospitalization. Nevertheless, today PAH still r...
Developing new treatments for pulmonary arterial hypertension (PAH) is a challenge. We have enjoyed ...
Pulmonary arterial hypertension (PAH) is a severe condition with a high mortality rate despite advan...
Pulmonary arterial hypertension (PAH) is a rare disorder characterized by progressive obliteration o...
Background. Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by an ...
Pulmonary arterial hypertension (PAH) is a rare disease characterized by pulmonary vascular remodeli...
Pulmonary arterial hypertension (PAH) is a disease charac-terized by progressive remodeling of the d...
Pulmonary arterial hypertension (PAH) is a severe and debilitating disease characterised by vascular...
Copyright © 2010 S. Umar et al. This is an open access article distributed under the Creative Common...
Pulmonary arterial hypertension (PAH) is a rare and severe clinical condition characterized by lumin...
Pulmonary arterial hypertension (PAH) is a serious and progressive vascular disease characterized by...
A greater understanding of the epidemiology, pathogenesis, and pathophysiology of pulmonary artery h...
A greater understanding of the epidemiology, pathogenesis, and pathophysiology of pulmonary artery h...
Therapeutic options for pulmonary arterial hypertension (PAH) have increased over the last decades. ...
Abstract Pulmonary arterial hypertension (PAH) is a fatal disease associated with vasoconstrictio...
Pulmonary arterial hypertension (PAH), characterized by increased pulmonary vascular resistance and ...
Developing new treatments for pulmonary arterial hypertension (PAH) is a challenge. We have enjoyed ...
Pulmonary arterial hypertension (PAH) is a severe condition with a high mortality rate despite advan...
Pulmonary arterial hypertension (PAH) is a rare disorder characterized by progressive obliteration o...
Background. Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by an ...
Pulmonary arterial hypertension (PAH) is a rare disease characterized by pulmonary vascular remodeli...
Pulmonary arterial hypertension (PAH) is a disease charac-terized by progressive remodeling of the d...
Pulmonary arterial hypertension (PAH) is a severe and debilitating disease characterised by vascular...
Copyright © 2010 S. Umar et al. This is an open access article distributed under the Creative Common...
Pulmonary arterial hypertension (PAH) is a rare and severe clinical condition characterized by lumin...
Pulmonary arterial hypertension (PAH) is a serious and progressive vascular disease characterized by...
A greater understanding of the epidemiology, pathogenesis, and pathophysiology of pulmonary artery h...
A greater understanding of the epidemiology, pathogenesis, and pathophysiology of pulmonary artery h...
Therapeutic options for pulmonary arterial hypertension (PAH) have increased over the last decades. ...
Abstract Pulmonary arterial hypertension (PAH) is a fatal disease associated with vasoconstrictio...
Pulmonary arterial hypertension (PAH), characterized by increased pulmonary vascular resistance and ...
Developing new treatments for pulmonary arterial hypertension (PAH) is a challenge. We have enjoyed ...
Pulmonary arterial hypertension (PAH) is a severe condition with a high mortality rate despite advan...
Pulmonary arterial hypertension (PAH) is a rare disorder characterized by progressive obliteration o...